Partial contribution of polyamines to the relaxant effect of 17α-estradiol in rat uterine smooth muscle

General Pharmacology

Volumn 30, Issue 1, 1998, Pages 71-77

  Gutiérrez, Mercedes ^a   Fernández, Ana I ^a   Revuelta, M Pilar ^a   Cantabrana, Begoña ^a   Hidalgo, Agustin ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

17 estradiol; Calcium; Polyamines; Rat uterus

Indexed keywords

17ALPHA ESTRADIOL; ADENOSINE 3',5' PHOSPHOROTHIOATE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP PHOSPHODIESTERASE; DACTINOMYCIN; EFLORNITHINE; GENISTEIN; POTASSIUM CHLORIDE; TAMOXIFEN; VANADIC ACID;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; MYOMETRIUM; NONHUMAN; PRIORITY JOURNAL; RAT; UTERUS RELAXATION;

EID: 0031986181     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00073-6     Document Type: Article

References (43)

1. Batra S. (1980) Estrogen and smooth muscle function. Trends Pharmacol. Sci. 2, 388-391.
2. Batra S. and Bengtsson B. (1978) Effects of diethylstilbestrol and ovarian steroids on the contractile responses and calcium movements in rat uterine smooth muscle. J. Physiol. 276, 329-342.
3. Bose D., Elliot D., Kobayashi T., Templeton J. F., Kumar V. P. S. and LaBella F. S. (1988) 14β-Hydroxyprogesterone binds to the digitalis receptor, inhibits the sodium pump and enhances cardiac contractility. Br. J. Pharmacol. 93, 453-461.
4. Cabral R., Gutierrez M., Fernandez A. I., Cantabrana B. and Hidalgo A. (1994) Progesterone and pregnanolone derivatives relaxing effect on smooth muscle. Gen. Pharmacol. 25, 173-178.
5. Cantabrana B. and Hidalgo A. (1992) Effects of non-steroidal antioestrogens in rat uterus "in vitro". Pharmacology 45, 329-337.
6. Cantabrana B., Fernandez A. I., Gutierrez M. and Hidalgo A. (1993) Participación de mecanismos genómicos en la relajación del músculo liso por estrógenos. Rev. Farmacol. Clin. Exp. (Special Issue) 235p.
7. Elliot R. A., Castleden C. M., Miodrag A. and Kirwan P. (1992) The direct effects of diethylstilboestrol and nifedipine on the contractile responses of isolated human and rat detrusor muscles. Eur. J. Clin. Pharmacol. 43, 149-155.
8. Fernández A. I., Cantabrana B. and Hidalgo A. (1993) Estrogen and antiestrogen non-genomic effect in rat uterus contraction in calcium-free solution. Gen. Pharmacol. 24, 391-395.
9. Fernández A. I., Cantabrana B. and Hidalgo A. (1992a) Mediators involved in the rat uterus contraction in calcium-free solution. Gen. Pharmacol. 23, 291-296.
10. Fernández A. I., Martínez V., Cantabrana B., Hidalgo A. (1992b) Differential effect of calcium and Bay K 8644 on the inhibitory action of estrogens in the rat uterus. Gen. Pharmacol. 23, 549-554.
11. Fernández A. I., Cantabrana B. and Hidalgo A. (1993) Effects of phorbol 12,13-dibutyrate and H-7 in extravascular smooth muscle contraction. Pharmacology 47, 152-157.
12. Fernández A. I., Cantabrana B., Sánchez M. and Hidalgo A. (1995) Extra-cellular and intracellular effects of polyamines on smooth muscle contractions. Life Sci. 57, 855-861.
13. Garcia-Valencia V., Andrés-Trelles F. and Hidalgo A. (1989) Efecto de 5-alfa y 5-beta-dihidrotestosterona en aurícula izquierda de rata in vitro. Rev. Farmacol. Clin. Exp. 6, 15-21.
14. Garcia-Valencia V., Sanchez M., Gutierrez M., Cantabrana B. and Hidalgo A. (1991) Effects of steroidal and non-steroidal anti-androgens on the left atrium of the rat in vitro. Gen. Pharmacol. 22, 1081-1086.
15. Godfraind T. (1994) Calcium antagonists and vasodilatation. Pharmac. Ther. 64, 37-75.
16. Goyache F. M., Gutiérrez M., Hidalgo A. and Cantabrana B. (1995) Non-genomic effects of catecholestrogens in the In Vitro rat uterine contraction. Gen. Pharmacol. 26, 219-223.
17. Gutiérrez M., Martinez V, Cantabrana B. and Hidalgo A. (1994) Genomic and non-genomic effects of steroidal drugs on smooth muscle contraction in vitro. Life Sci. 55, 437-443.
18. Haukkamaa M. (1987) Membrane associated steroid hormone receptors. In Steroid Hormone Receptors (Edited by Clark C. R.), pp. 155-169. VCH Press, New York.
19. Ivorra M. D., Chuliá S., Noguera M. A. and D'Ocon M. P. (1994) Intervention of two voltage-dependent calcium-entry pathways in the contractile response to acetylcholine and KCl in rat uterus. Pharmacology 49, 33-41.
20. Karaki H. and Weiss G. (1988) Calcium release in smooth muscle. Life Sci. 42, 111-122.
21. 2+-dependent cyclic nucleotide phosphodiesterase. Biochemistry 18, 722-729.
22. Kostrzewska A., Laudánski T. and Batra S. (1993) Effect of ovarian steroids and diethylstilbestrol on the contractile responses of the human myometrium and intramyometrial arteries. Eur. J. Pharmacol. 233, 127-134.
23. Kubli-Garfias C. (1984) Physiological role of 5 alpha and 5 beta progester-one metabolites on the CNS. Trends Pharmacol. Sci. 4, 439-442.
24. LaBella F. S., Song Kim, R. and Templeton J. (1978) Opiate receptor binding activity of 17-alpha estrogenic steroids. Life Sci. 23, 1797-1804.
25. Lopez M. G., Abad F., Sancho C., Pascual R. de, Borges R., Maroto R., Dixon W. and García A. G. (1991) Membrane-mediated effects of the steroid 17α-estradiol on adrenal catecholamme release. J. Pharmacol. Exp. Ther. 259, 279-285.
26. Marton L. J. and Pegg A. E. (1995) Polyamines as targets for therapeutic intervention. Annu. Rev. Pharmacol. Toxicol. 35, 55-91.
27. McEwen B. S. (1991) Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 12, 141-147.
28. Moss R. L. and Dudley C. A. (1984) Molecular aspects of the interaction between estrogen and the membrane excitability of hypothalamic nerve cells. In Progress in Brain Research (Edited by De Vries G. J.), pp 3-22. Elsevier, Amsterdam.
29. Parker-Botelho L. H., Rothermel J. D., Coombs R. V. and Jastorff B. (1988) cAMP analog antagonists of cAMP action. Methods Enzymol. 159, 159-172.
30. Pegg A. E. (1986) Recent advances in the biochemistry of polyamines in eukaryotes. Biochern. J. 234, 249-262.
31. Pérez Vallina J. R., Menéndez L., Cantabrana B. and Hidalgo A. (1995) Involvement of cAMP in the spasmolytic effect of diclofenac on rat uterine smooth muscle. Pharm. Sci. 1, 185-187.
32. Perusquia M., Garcia-Yañez E., Ibañez R. and Kubli-Garfias C. (1990) Non-genomic mechanism of action of Δ-4 and 5-reduced androgens and progestins on the contractility of isolated rat myometrium. Life Sci. 47, 1547-1553.
33. Pietras R. J. and Szego C. M. (1993) Estrogen receptors in uterine plasma membrane. J. Steroid Biochem. 11, 1471-1483.
34. Raddino R., Manca C., Poli E., Bolognesi R. and Visioli O. (1986) Effects of 17β-estradiol on the isolated rabbit heart. Arch. Int. Pharmacodyn. 281, 57-65.
35. Rodriguez J., Garcia de Boto M. J. and Hidalgo A. (1996) Mechanisms involved in the relaxant effect of estrogens on rat aorta strips. Life Sci. 58, 607-615.
36. Salas E., Lopez M. G., Villarroya M., Sánchez-Garcia P., Pascual R. de, Dixon W.R. and García A. G. (1994) Endothelium-independent relaxation by 17α-estradiol of pig coronary arteries. Eur. J. Pharmacol. 258, 47-55.
37. Sanchez Aparício J. A., Gutierrez M., Hidalgo A. and Cantabrana B. (1993) Effects of androgens on isolated rat uterus. Life Sci. 53, 269-274.
38. Schumacher M. (1990) Rapid membrane effects of steroid hormones: an emerging concept in neuroendocrinology. Trends Neurosci. 13, 359-362.
39. Scott R. H., Sutton K. G. and Dolphin A. C. (1993) Interactions of polyamines with neuronal ion channels. Trends Neurosci. 16, 153-160.
40. Szego C. M. (1984) Mechanisms of hormone action: parallels in receptor-mediated signal propagation for steroid and peptide effectors. Life Sci. 35, 2383-2396.
41. Templeton J. F., Kumar V. P. S., Cote D., Bose D., Elliot D., Kim R. S. and Labella F. S. (1987) Progesterone derivatives that bind to the digitalis receptor: synthesis of 14β-hydroxyprogesterone. A novel steroid with positive inotropic activity. J. Med. Chem. 30, 1505-1509.
42. Truss M. and Beato M. (1993) Steroid hormone receptors: Interaction with deoxyribonucleic acid and transcription factors. Endocrine Rev. 14, 459-479.
43. Wehling M., Christ M. and Gerzer R. (1993) Aldosterone-specific membrane receptors and related rapid, non-genomic effects. Trends Pharmacol. Sci. 14, 1-3.